Canada · Delayed Price · Currency is CAD Vantex Resources Statistics
Total Valuation
TSXV:VAX has a market cap or net worth of CAD 601,157. The enterprise value is 475,776.
| Market Cap | 601,157 |
| Enterprise Value | 475,776 |
Important Dates
The next estimated earnings date is Friday, September 25, 2026.
| Earnings Date | Sep 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:VAX has 4.81 million shares outstanding.
| Current Share Class | 4.81M |
| Shares Outstanding | 4.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 66.28 |
| P/TBV Ratio | 66.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.36.
| Current Ratio | 1.06 |
| Quick Ratio | 0.97 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.60 |
Financial Efficiency
Return on equity (ROE) is -185.73% and return on invested capital (ROIC) is -75.86%.
| Return on Equity (ROE) | -185.73% |
| Return on Assets (ROA) | -42.57% |
| Return on Invested Capital (ROIC) | -75.86% |
| Return on Capital Employed (ROCE) | -2,271.06% |
| Weighted Average Cost of Capital (WACC) | 2.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -639 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +116.67% in the last 52 weeks. The beta is -0.35, so TSXV:VAX's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | +116.67% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 44.95 |
| Average Volume (20 Days) | 13,037 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -205,985 |
| Pretax Income | -236,685 |
| Net Income | -236,046 |
| EBITDA | -205,985 |
| EBIT | -205,985 |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 137,731 in cash and 12,347 in debt, with a net cash position of 125,384 or 0.03 per share.
| Cash & Cash Equivalents | 137,731 |
| Total Debt | 12,347 |
| Net Cash | 125,384 |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 9,070 |
| Book Value Per Share | 0.00 |
| Working Capital | 9,070 |
Cash Flow
| Operating Cash Flow | -223,669 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -9,524 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:VAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -39.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 18, 2018. It was a reverse split with a ratio of 0.2.
| Last Split Date | May 18, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |